Georges Morgant
Papers
1
Total Citations
53
H-Index
1
About
Dr. Georges Morgant is a leading medicinal chemist whose research focuses on the pharmacology of ion channels, with a particular emphasis on chloride transport and cystic fibrosis (CF) therapeutics. His most cited work, a 2004 study on benzoquinoliziniums, represents a significant contribution to the field by identifying novel small-molecule activators of the cystic fibrosis transmembrane conductance regulator (CFTR) channel. This research is critical because, as Dr. Morgant notes, the pharmacology of chloride channels remains poorly understood despite their essential roles in cell volume regulation and electrical excitability. His paper, which integrates synthesis, structure-activity relationships (SAR), and crystal structure analysis, provides a foundational framework for developing drugs that target both wild-type and mutant CFTR channels—a major challenge in treating CF. With 53 citations, this work has influenced subsequent drug discovery efforts aimed at correcting the defective chloride transport underlying the disease. Dr. Morgant’s contributions bridge chemistry and biology, offering a pathway to better understand and treat channelopathies.
Research Focus
Key Achievements
Top Papers
- 1